These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2671 related items for PubMed ID: 31832001

  • 1. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 2. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW.
    Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073834
    [Abstract] [Full Text] [Related]

  • 3. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 4. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L, Fang K, Dan X, Gu M.
    Lipids Health Dis; 2019 Jan 08; 18(1):11. PubMed ID: 30621686
    [Abstract] [Full Text] [Related]

  • 5. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 08; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 6. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC.
    Cell Physiol Biochem; 2018 Feb 08; 49(5):1870-1884. PubMed ID: 30235452
    [Abstract] [Full Text] [Related]

  • 7. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M.
    J Hepatol; 2014 May 08; 60(5):1017-25. PubMed ID: 24362075
    [Abstract] [Full Text] [Related]

  • 8. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B.
    Cell Physiol Biochem; 2016 May 08; 40(3-4):453-464. PubMed ID: 27889747
    [Abstract] [Full Text] [Related]

  • 9. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
    Alberdi G, Rodríguez VM, Macarulla MT, Miranda J, Churruca I, Portillo MP.
    Nutrition; 2013 Mar 08; 29(3):562-7. PubMed ID: 23274094
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF, Wang XN, Huang CC, Hu L, Xiao YF, Guan XH, Qian YS, Deng KY, Xin HB.
    Lipids Health Dis; 2017 Apr 27; 16(1):82. PubMed ID: 28449683
    [Abstract] [Full Text] [Related]

  • 11. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
    Li N, Yin L, Shang J, Liang M, Liu Z, Yang H, Qiang G, Du G, Yang X.
    Biomed Pharmacother; 2023 Sep 27; 165():115113. PubMed ID: 37418974
    [Abstract] [Full Text] [Related]

  • 12. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X, Liu Z, Wang J.
    Phytomedicine; 2023 Oct 27; 119():155005. PubMed ID: 37562090
    [Abstract] [Full Text] [Related]

  • 13. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways.
    Tamilmani P, Sathibabu Uddandrao VV, Chandrasekaran P, Saravanan G, Brahma Naidu P, Sengottuvelu S, Vadivukkarasi S.
    Clin Res Hepatol Gastroenterol; 2023 Dec 27; 47(10):102231. PubMed ID: 37865226
    [Abstract] [Full Text] [Related]

  • 14. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
    Shen Z, Liang X, Rogers CQ, Rideout D, You M.
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar 27; 298(3):G364-74. PubMed ID: 20007851
    [Abstract] [Full Text] [Related]

  • 15. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK, Dai W, Zheng YW, Zhao SP.
    Mol Med; 2019 Jun 13; 25(1):26. PubMed ID: 31195981
    [Abstract] [Full Text] [Related]

  • 16. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X, Liu Q, Li Y, Tang Q, Wu T, Chen L, Pu S, Zhao Y, Zhang G, Huang C, Zhang J, Zhang Z, Huang Y, Zou M, Shi X, Jiang W, Wang R, He J.
    Adipocyte; 2020 Dec 13; 9(1):484-494. PubMed ID: 32835596
    [Abstract] [Full Text] [Related]

  • 17. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y.
    Mol Metab; 2017 Jan 13; 6(1):138-147. PubMed ID: 28123944
    [Abstract] [Full Text] [Related]

  • 18. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020 Jan 13; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 19. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
    Li Q, Tan JX, He Y, Bai F, Li SW, Hou YW, Ji LS, Gao YT, Zhang X, Zhou ZH, Yu Z, Fang M, Gao YQ, Li M.
    Int J Biol Sci; 2022 Jan 13; 18(4):1594-1611. PubMed ID: 35280674
    [Abstract] [Full Text] [Related]

  • 20. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA, Hwang YJ, Kim GR, Choe JS.
    BMC Complement Altern Med; 2015 Oct 05; 15():347. PubMed ID: 26438035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 134.